# Huntsman CORP: financial statements, quarterly

HUN · NYSE · CIK 1307954 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hun.md) · [Financials](/companies/hun/financials.md) · [Filings](/companies/hun/filings.md) · [Insiders](/companies/hun/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hun/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,596](/filings/0001437749-24-024923.md) | [1,506](/filings/0001437749-24-033260.md) | [1,403 d](/filings/0001437749-26-004524.md) | [1,470](/filings/0001437749-25-014251.md) | [1,574](/filings/0001437749-25-024325.md) | [1,540](/filings/0001437749-25-033805.md) | [1,452 d](/filings/0001437749-26-004524.md) | [1,410](/filings/0001437749-26-014346.md) | [1,458](/filings/0001437749-25-024325.md) | [1,460](/filings/0001437749-25-033805.md) | [1,355 d](/filings/0001437749-26-004524.md) | [1,420](/filings/0001437749-26-014346.md) |
| Cost of revenue | $m | [1,342](/filings/0001437749-24-024923.md) | [1,275](/filings/0001437749-24-033260.md) | [1,251 d](/filings/0001437749-26-004524.md) | [1,269](/filings/0001437749-25-014251.md) | [1,331](/filings/0001437749-25-024325.md) | [1,306](/filings/0001437749-25-033805.md) | [1,264 d](/filings/0001437749-26-004524.md) | [1,209](/filings/0001437749-26-014346.md) | [1,276](/filings/0001437749-25-024325.md) | [1,256](/filings/0001437749-25-033805.md) | [1,191 d](/filings/0001437749-26-004524.md) | [1,237](/filings/0001437749-26-014346.md) |
| Gross profit | $m | [254](/filings/0001437749-24-024923.md) | [231](/filings/0001437749-24-033260.md) | [152 d](/filings/0001437749-26-004524.md) | [201](/filings/0001437749-25-014251.md) | [243](/filings/0001437749-25-024325.md) | [234](/filings/0001437749-25-033805.md) | [188 d](/filings/0001437749-26-004524.md) | [201](/filings/0001437749-26-014346.md) | [182](/filings/0001437749-25-024325.md) | [204](/filings/0001437749-25-033805.md) | [164 d](/filings/0001437749-26-004524.md) | [183](/filings/0001437749-26-014346.md) |
| Research and development | $m | [29.0](/filings/0001437749-24-024923.md) | [28.0](/filings/0001437749-24-033260.md) | [28.0 d](/filings/0001437749-26-004524.md) | [31.0](/filings/0001437749-25-014251.md) | [33.0](/filings/0001437749-25-024325.md) | [27.0](/filings/0001437749-25-033805.md) | [30.0 d](/filings/0001437749-26-004524.md) | [32.0](/filings/0001437749-26-014346.md) | [33.0](/filings/0001437749-25-024325.md) | [29.0](/filings/0001437749-25-033805.md) | [26.0 d](/filings/0001437749-26-004524.md) | [29.0](/filings/0001437749-26-014346.md) |
| Selling, general and administrative | $m | [167](/filings/0001437749-24-024923.md) | [165](/filings/0001437749-24-033260.md) | [169 d](/filings/0001437749-26-004524.md) | [176](/filings/0001437749-25-014251.md) | [176](/filings/0001437749-25-024325.md) | [153](/filings/0001437749-25-033805.md) | [166 d](/filings/0001437749-26-004524.md) | [166](/filings/0001437749-26-014346.md) | [160](/filings/0001437749-25-024325.md) | [163](/filings/0001437749-25-033805.md) | [181 d](/filings/0001437749-26-004524.md) | [163](/filings/0001437749-26-014346.md) |
| Operating income | $m | [50.0](/filings/0001437749-24-024923.md) | [27.0](/filings/0001437749-24-033260.md) | [(54.0) d](/filings/0001437749-26-004524.md) | [(38.0)](/filings/0001437749-25-014251.md) | [34.0](/filings/0001437749-25-024325.md) | [42.0](/filings/0001437749-25-033805.md) | [(63.0) d](/filings/0001437749-26-004524.md) | [42.0](/filings/0001437749-26-014346.md) | [(120)](/filings/0001437749-25-024325.md) | [6.0](/filings/0001437749-25-033805.md) | [(59.0) d](/filings/0001437749-26-004524.md) | [(16.0)](/filings/0001437749-26-014346.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [28.0](/filings/0001437749-24-024923.md) | [27.0](/filings/0001437749-24-033260.md) | [(2.0) d](/filings/0001437749-26-004524.md) | [(20.0)](/filings/0001437749-25-014251.md) | [13.0](/filings/0001437749-25-024325.md) | [39.0](/filings/0001437749-25-033805.md) | [29.0 d](/filings/0001437749-26-004524.md) | [15.0](/filings/0001437749-26-014346.md) | [7.0](/filings/0001437749-25-024325.md) | [3.0](/filings/0001437749-25-033805.md) | [1.0 d](/filings/0001437749-26-004524.md) | [11.0](/filings/0001437749-26-014346.md) |
| Net income | $m | [19.0](/filings/0001437749-24-024923.md) | [0.0](/filings/0001437749-24-033260.md) | [(71.0) d](/filings/0001437749-26-004524.md) | [(37.0)](/filings/0001437749-25-014251.md) | [22.0](/filings/0001437749-25-024325.md) | [(33.0)](/filings/0001437749-25-033805.md) | [(141) d](/filings/0001437749-26-004524.md) | [(5.0)](/filings/0001437749-26-014346.md) | [(158)](/filings/0001437749-25-024325.md) | [(25.0)](/filings/0001437749-25-033805.md) | [(96.0) d](/filings/0001437749-26-004524.md) | [(53.0)](/filings/0001437749-26-014346.md) |
| Diluted EPS | $ per share | [0.11](/filings/0001437749-24-024923.md) | [0.00](/filings/0001437749-24-033260.md) | not reported | [(0.22)](/filings/0001437749-25-014251.md) | [0.13](/filings/0001437749-25-024325.md) | [(0.19)](/filings/0001437749-25-033805.md) | not reported | [(0.03)](/filings/0001437749-26-014346.md) | [(0.92)](/filings/0001437749-25-024325.md) | [(0.14)](/filings/0001437749-25-033805.md) | not reported | [(0.31)](/filings/0001437749-26-014346.md) |
| Basic EPS | $ per share | [0.11](/filings/0001437749-24-024923.md) | [0.00](/filings/0001437749-24-033260.md) | not reported | [(0.22)](/filings/0001437749-25-014251.md) | [0.13](/filings/0001437749-25-024325.md) | [(0.19)](/filings/0001437749-25-033805.md) | not reported | [(0.03)](/filings/0001437749-26-014346.md) | [(0.92)](/filings/0001437749-25-024325.md) | [(0.14)](/filings/0001437749-25-033805.md) | not reported | [(0.31)](/filings/0001437749-26-014346.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [502](/filings/0001437749-23-021355.md) | [496](/filings/0001437749-23-029731.md) | [540](/filings/0001437749-25-004205.md) | [552](/filings/0001437749-24-014574.md) | [335](/filings/0001437749-24-024923.md) | [330](/filings/0001437749-24-033260.md) | [340](/filings/0001437749-26-004524.md) | [334](/filings/0001437749-25-014251.md) | [399](/filings/0001437749-25-024325.md) | [468](/filings/0001437749-25-033805.md) | [429](/filings/0001437749-26-014346.md) | [369](/filings/0001437749-26-014346.md) |
| Current assets | $m | [2,520](/filings/0001437749-23-021355.md) | [2,394](/filings/0001437749-23-029731.md) | [2,314](/filings/0001437749-25-004205.md) | [2,443](/filings/0001437749-24-014574.md) | [2,254](/filings/0001437749-24-024923.md) | [2,293](/filings/0001437749-24-033260.md) | [2,125](/filings/0001437749-26-004524.md) | [2,286](/filings/0001437749-25-014251.md) | [2,208](/filings/0001437749-25-024325.md) | [2,182](/filings/0001437749-25-033805.md) | [2,064](/filings/0001437749-26-014346.md) | [2,179](/filings/0001437749-26-014346.md) |
| Total assets | $m | [7,553](/filings/0001437749-23-021355.md) | [7,369](/filings/0001437749-23-029731.md) | [7,248](/filings/0001437749-25-004205.md) | [7,572](/filings/0001437749-24-014574.md) | [7,317](/filings/0001437749-24-024923.md) | [7,334](/filings/0001437749-24-033260.md) | [7,114](/filings/0001437749-26-004524.md) | [7,232](/filings/0001437749-25-014251.md) | [7,147](/filings/0001437749-25-024325.md) | [7,082](/filings/0001437749-25-033805.md) | [7,015](/filings/0001437749-26-014346.md) | [7,131](/filings/0001437749-26-014346.md) |
| Current liabilities | $m | [1,176](/filings/0001437749-23-021355.md) | [1,271](/filings/0001437749-23-029731.md) | [1,172](/filings/0001437749-25-004205.md) | [1,579](/filings/0001437749-24-014574.md) | [1,729](/filings/0001437749-24-024923.md) | [1,560](/filings/0001437749-24-033260.md) | [1,565](/filings/0001437749-26-004524.md) | [1,540](/filings/0001437749-25-014251.md) | [1,544](/filings/0001437749-25-024325.md) | [1,601](/filings/0001437749-25-033805.md) | [1,589](/filings/0001437749-26-014346.md) | [1,719](/filings/0001437749-26-014346.md) |
| Total liabilities | $m | [3,707](/filings/0001437749-23-021355.md) | [3,715](/filings/0001437749-23-029731.md) | [3,770](/filings/0001437749-25-004205.md) | [4,178](/filings/0001437749-24-014574.md) | [3,981](/filings/0001437749-24-024923.md) | [3,989](/filings/0001437749-24-033260.md) | [3,951](/filings/0001437749-26-004524.md) | [4,061](/filings/0001437749-25-014251.md) | [4,086](/filings/0001437749-25-024325.md) | [4,081](/filings/0001437749-25-033805.md) | [4,058](/filings/0001437749-26-014346.md) | [4,229](/filings/0001437749-26-014346.md) |
| Long-term debt | $m | [1,562](/filings/0001437749-23-021355.md) | [1,493](/filings/0001437749-23-029731.md) | [1,676](/filings/0001437749-25-004205.md) | [1,660](/filings/0001437749-24-014574.md) | [1,344](/filings/0001437749-24-024923.md) | [1,513](/filings/0001437749-24-033260.md) | [1,510](/filings/0001437749-26-004524.md) | [1,670](/filings/0001437749-25-014251.md) | [1,663](/filings/0001437749-25-024325.md) | [1,630](/filings/0001437749-25-033805.md) | [1,658](/filings/0001437749-26-014346.md) | [1,680](/filings/0001437749-26-014346.md) |
| Current portion of debt | $m | [11.0](/filings/0001437749-23-021355.md) | [113](/filings/0001437749-23-029731.md) | [12.0](/filings/0001437749-25-004205.md) | [396](/filings/0001437749-24-014574.md) | [576](/filings/0001437749-24-024923.md) | [346](/filings/0001437749-24-033260.md) | [325](/filings/0001437749-26-004524.md) | [284](/filings/0001437749-25-014251.md) | [372](/filings/0001437749-25-024325.md) | [378](/filings/0001437749-25-033805.md) | [353](/filings/0001437749-26-014346.md) | [376](/filings/0001437749-26-014346.md) |
| Shareholders' equity | $m | [3,615](/filings/0001437749-23-021355.md) | [3,429](/filings/0001437749-23-029731.md) | [3,251](/filings/0001437749-25-004205.md) | [3,152](/filings/0001437749-24-014574.md) | [3,114](/filings/0001437749-24-024923.md) | [3,112](/filings/0001437749-24-033260.md) | [2,959](/filings/0001437749-26-004524.md) | [2,951](/filings/0001437749-25-014251.md) | [2,828](/filings/0001437749-25-024325.md) | [2,766](/filings/0001437749-25-033805.md) | [2,750](/filings/0001437749-26-014346.md) | [2,681](/filings/0001437749-26-014346.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [36.0 d](/filings/0001437749-24-024923.md) | [163 d](/filings/0001437749-24-033260.md) | [164 d](/filings/0001437749-26-004524.md) | [(65.0)](/filings/0001437749-25-014251.md) | [46.0 d](/filings/0001437749-25-024325.md) | [129 d](/filings/0001437749-25-033805.md) | [153 d](/filings/0001437749-26-004524.md) | [(74.0)](/filings/0001437749-26-014346.md) | [91.0 d](/filings/0001437749-25-024325.md) | [196 d](/filings/0001437749-25-033805.md) | [76.0 d](/filings/0001437749-26-004524.md) | [(53.0)](/filings/0001437749-26-014346.md) |
| Capital expenditure | $m | [51.0 d](/filings/0001437749-24-024923.md) | [50.0 d](/filings/0001437749-24-033260.md) | [83.0 d](/filings/0001437749-26-004524.md) | [42.0](/filings/0001437749-25-014251.md) | [50.0 d](/filings/0001437749-25-024325.md) | [41.0 d](/filings/0001437749-25-033805.md) | [51.0 d](/filings/0001437749-26-004524.md) | [36.0](/filings/0001437749-26-014346.md) | [37.0 d](/filings/0001437749-25-024325.md) | [43.0 d](/filings/0001437749-25-033805.md) | [57.0 d](/filings/0001437749-26-004524.md) | [38.0](/filings/0001437749-26-014346.md) |
| Dividends paid | $m | [42.0](/filings/0001437749-25-004205.md) | [42.0](/filings/0001437749-25-004205.md) | [41.0](/filings/0001437749-25-004205.md) | [44.0](/filings/0001437749-25-014251.md) | [43.0](/filings/0001437749-25-004205.md) | [44.0](/filings/0001437749-25-004205.md) | [44.0](/filings/0001437749-25-004205.md) | [44.0](/filings/0001437749-26-014346.md) | [43.0 d](/filings/0001437749-25-024325.md) | [44.0 d](/filings/0001437749-25-033805.md) | [15.0 d](/filings/0001437749-26-004524.md) | [16.0](/filings/0001437749-26-014346.md) |
| Share repurchases | $m | [97.0 d](/filings/0001437749-24-024923.md) | [102 d](/filings/0001437749-24-033260.md) | [53.0 d](/filings/0001437749-26-004524.md) | [1.0](/filings/0001437749-25-014251.md) | [0.0 d](/filings/0001437749-25-024325.md) | [0.0 d](/filings/0001437749-25-033805.md) | [3.0 d](/filings/0001437749-26-004524.md) | [0.0](/filings/0001437749-25-014251.md) | [0.0 d](/filings/0001437749-25-024325.md) | [0.0 d](/filings/0001437749-25-033805.md) | [0.0 d](/filings/0001437749-26-004524.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [207](/filings/0001437749-23-021355.md) | [199](/filings/0001437749-23-029731.md) | [184](/filings/0001437749-24-014574.md) | [180](/filings/0001437749-24-024923.md) | [177](/filings/0001437749-24-033260.md) | [172](/filings/0001437749-25-014251.md) | [173](/filings/0001437749-25-024325.md) | [172](/filings/0001437749-25-033805.md) | [172](/filings/0001437749-26-014346.md) | [173](/filings/0001437749-25-024325.md) | [173](/filings/0001437749-25-033805.md) | [173](/filings/0001437749-26-014346.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 175,349,112 at 2026-04-22, from the cover of the [10-Q filed 2026-05-01](/filings/0001437749-26-014346.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.